Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
42.20
-0.34 (-0.81%)
At close: Nov 20, 2025, 4:00 PM EST
42.00
-0.20 (-0.46%)
After-hours: Nov 20, 2025, 5:02 PM EST
GNOM Holdings Information
GNOM is an equity ETF with a total of 51 individual holdings. The top holdings are Guardant Health stock at 5.38%, Illumina at 5.22%, Natera at 4.51%, BioMarin Pharmaceutical at 4.25%, and Vertex Pharmaceuticals at 4.25%.
Total Holdings
25
Top 10 Percentage
43.86%
Asset Class
Equity
ETF Category
Health
Assets
50.48M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GH | Guardant Health, Inc. | 5.38% |
| 2 | ILMN | Illumina, Inc. | 5.22% |
| 3 | NTRA | Natera, Inc. | 4.51% |
| 4 | BMRN | BioMarin Pharmaceutical Inc. | 4.25% |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | 4.25% |
| 6 | RNA | Avidity Biosciences, Inc. | 4.14% |
| 7 | MRNA | Moderna, Inc. | 4.10% |
| 8 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.08% |
| 9 | BNTX | BioNTech SE | 4.03% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.90% |
| 11 | PRAX | Praxis Precision Medicines, Inc. | 3.83% |
| 12 | QGEN | Qiagen N.V. | 3.82% |
| 13 | TECH | Bio-Techne Corporation | 3.81% |
| 14 | LEGN | Legend Biotech Corporation | 3.72% |
| 15 | CRSP | CRISPR Therapeutics AG | 3.48% |
| 16 | WGS | GeneDx Holdings Corp. | 3.07% |
| 17 | VCYT | Veracyte, Inc. | 2.84% |
| 18 | RARE | Ultragenyx Pharmaceutical Inc. | 2.81% |
| 19 | LLY | Eli Lilly and Company | 2.57% |
| 20 | HKG: 1548 | Genscript Biotech Corporation | 2.27% |
| 21 | BMY | Bristol-Myers Squibb Company | 2.25% |
| 22 | GILD | Gilead Sciences, Inc. | 2.18% |
| 23 | LON: AZN | AstraZeneca PLC | 2.18% |
| 24 | BEAM | Beam Therapeutics Inc. | 1.90% |
| 25 | TXG | 10x Genomics, Inc. | 1.63% |
As of Nov 18, 2025